[Stroke and combined oral contraceptives].
Rancurel
G
G
Kieffer
E
E
Buge
A
A
D000367:Age Factors; D000906:Antibodies; D001695:Biology; D001769:Blood; D001777:Blood Coagulation; D002319:Cardiovascular System; D002560:Cerebrovascular Circulation; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003710:Demography; D019049:Developed Countries; D004194:Disease; D004617:Embolism; D005060:Europe; D005123:Eye; D005193:Family Planning Services; D005602:France; D006973:Hypertension; D007109:Immunity; D007155:Immunologic Factors; D010827:Physiology; D011153:Population; D011154:Population Characteristics; D011157:Population Dynamics; D013923:Thromboembolism; D013927:Thrombosis; D013997:Time Factors; D014652:Vascular Diseases
D000906:Antibodies; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D007155:Immunologic Factors
Age Factors; Antibodies; Biology; Blood Coagulation Effects; Cardiovascular Effects; Cerebrovascular Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods; Demographic Factors; Developed Countries; Diseases; Embolism; Europe; Family Planning; France; Hematological Effects; Hemic System; Hypertension; Immunity; Immunologic Factors; Immunological Effects; Mediterranean Countries; Ophthalmological Effects; Oral Contraceptives; Oral Contraceptives, Low-dose; Physiology; Population; Population Characteristics; Population Dynamics; Thromboembolism; Thrombosis; Time Factors; Vascular Diseases; Western Europe